Q Fever (Coxiella burnetii)

Reportable by Laboratories and Providers

About this Reportable Disease

Infectious agent: Coxiella burnetii

Description of illness:  Q fever is a disease caused by the bacteria Coxiella burnetii which is found worldwide. The bacteria naturally infects some animals, such as goats, sheep and cattle. C. burnetii bacteria are found in the birth products (i.e. placenta, amniotic fluid), urine, feces, and milk of infected animals. People can get infected by breathing in dust that has been contaminated by infected animal feces, urine, milk, and birth products. Some people never get sick; however those that do usually develop flu-like symptoms including fever, chills, fatigue, and muscle pain.

Interactive Disease Data


Laboratory Reporting for this Disease

Coxiella burnetii

TEST NAME Coxiella burnetii  
DISEASE/DISORDER Q Fever  
ALTERNATE NAME(S)    
METHODOLOGY Coxiella burnetii Warrior Panel/FilmArray Biofire  
SPECIAL INSTRUCTIONS

Contact the Bioterrorism laboratory before submission

 
ORDERING INFORMATION

Lab Web Portal

TDH DLS Requisition:  PH-4263 Clinical Select Agent Rule-Out Submission Requisition

 

Specimen Requirements

Patient Preparation
  • None
 
Specimen Collection
  • Acceptable Specimen Sources/Type(s) for Submission

-  Whole blood: Collect 2 EDTA (purple top) plastic blood collection tubes

-  Minimum volume per tube: 4 mL for adult and 1 mL per child

 
Specimen Labeling
  • Specimen should be labeled with at least two unique patient identifiers along with specimen source and match accompanying test order.
 
Specimen Processing
  • Contact Bioterrorism laboratory prior to shipment to determine appropriate specimen handling based on LRN protocols.
 
Specimen Storage and Preservation
  • Contact Bioterrorism laboratory prior to shipment to determine appropriate specimen handling based on LRN protocols.
 
Specimen Transport
  • Contact Bioterrorism laboratory prior to shipment to determine appropriate specimen handling based on LRN protocols.
  • All infectious substance shipments must conform to U.S. Department of Transportation (DOT) Hazardous Materials Regulations (HMR 49 C.F.R. Parts 171-180). 
 
Specimen Acceptability and Rejection
  • Contact Bioterrorism laboratory prior to shipment to determine appropriate specimen handling based on LRN protocols.
 
Testing Location
  • Nashville
 

Laboratory Reporting

Reporting requirements apply to all laboratories located within Tennessee, as well as laboratories outside of Tennessee that test residents of Tennessee, including laboratories located within healthcare facilities. Healthcare providers and laboratories in the same healthcare facility both have a duty to report. The type of organisms and analytes laboratories must report to TDH for 2026 are indicated, and there are several ways laboratories can report results to TDH.

Information about this Reportable Disease for Healthcare Providers

Clinical Summary

It’s caused by the bacterium Coxiella burnetii, primarily found in sheep, goats, cattle and their birthing products.

Many people infected never become ill, but those who do often get flu-like symptoms: fever, chills, fatigue, muscle aches. 

The disease can progress to pneumonia, hepatitis, and in rare cases a chronic form may involve heart or vascular infection (endocarditis).

The main route of human infection is inhaling dust or aerosols contaminated with animal waste or birth materials; unpasteurized milk is a minor route.

Treatment for symptomatic acute cases uses the antibiotic doxycycline; chronic cases require prolonged combination therapy and are more difficult to manage.


Healthcare Provider Reporting

Healthcare reporting requirements apply to all providers located within Tennessee, as well as providers whose patients reside in Tennessee.

Providers must report cases of all diseases and conditions listed through one of these methods:

• Mail or fax a completed PH-1600 form to your local health department or fax to the state health office at (615) 741-3857

• Send automatically via electronic case reporting (eCR). See this TDH webpage for more information on eCR, register at the Trader Partner Registration website, or contact MU.Health@tn.gov for assistance.

• Submit online via NBS. NBS is TDH's reportable disease system. To request an NBS account for reporting Complete this user survey to request an NBS account for reporting

• Blood lead levels can be sent via fax ( (615) 741-3857), entered online, or reported using the instructions at this link

Information about this Reportable Disease for the Public

What It Is

Q fever is caused by the bacterium Coxiella burnetii, which naturally infects animals such as goats, sheep, and cattle. 

The bacterium is shed in animal birth products (placenta, amniotic fluid), urine, feces, and milk of infected animals. 

Humans most often get infected by inhaling dust contaminated with those animal materials; direct contact or ingestion of raw milk may also be routes. 

The disease is found worldwide and is considered a zoonosis (animal-to-human transmitted disease). 

Many infected people show no symptoms; infection doesn’t always lead to illness. 

Types

Acute Q fever – the initial illness that follows recent infection; may be mild or more severe, but typically presents soon after exposure. 

Chronic Q fever – develops months or even years after the initial infection in a minority of cases; often life-threatening if untreated. 

Chronic Q fever commonly involves endocarditis (infection of heart valves) but may also involve bone, liver, vascular aneurysms, or other organs.

Risk for chronic progression is higher in persons with heart valve defects, vascular grafts, aneurysms, immune suppression, or pregnant women.

Many people infected never become ill (asymptomatic), so types overlap with the spectrum of illness from no symptoms → acute → chronic. 

Signs and Symptoms

For those who become ill, initial symptoms often resemble influenza: fever, chills, fatigue, muscle aches, and headache. 

Some people develop cough (often dry), chest pain, nausea, vomiting, or diarrhea; liver inflammation (hepatitis) and lung involvement may occur.

The incubation period (time from exposure to symptoms) is generally about 2–3 weeks.

A small percentage (< 5 %) of infected persons can go on to develop a chronic form of the disease, which may involve heart valve infection (endocarditis) and other serious complications.

In chronic cases, symptoms may include night sweats, weight loss, fatigue, shortness of breath, or swelling of limbs due to heart involvement. 

Treatment

Most people with mild or asymptomatic infection recover without antibiotic treatment.

For symptomatic acute Q fever, the first-line antibiotic recommended is Doxycycline (e.g., adult: 100 mg twice daily for 14 days) when diagnosis is suspected.

Treatment should begin as soon as Q fever is suspected (even if lab results pending) for best outcomes.

For chronic Q fever (especially endocarditis or vascular infection), long-term antibiotic combination therapy is used (e.g., doxycycline + Hydroxychloroquine) for many months (sometimes ≥ 18 months). 

There is currently no vaccine for Q fever available for use in the United States.

This Page Last Updated: March 25, 2026 at 8:53 PM